Georgiamune Funding & Investors
Georgiamune is an immunotherapy company focused on oncology breakthroughs. The company employs next-generation immunotherapeutic and homeostatic therapies for cancer and autoimmune illnesses, allowing patients to recover quickly from cancer.
georgiamune.comTotal Amount Raised: $75,000,000
Georgiamune Funding Rounds
Series A
$75,000,000
Series A Investors
Bioventures InvestorsCatalio Capital ManagementGeneral CatalystParker Institute for Cancer ImmunotherapyAlexandria Real Estate EquitiesVerition Fund ManagementMubadala Capital Ventures
Funding info provided by Diffbot.